Abstract
Purpose
The purpose of this paper was to assess the impact of survivorship care plan (SCP) provision and moderating factors on health care use following endometrial cancer treatment.
Methods
Women newly diagnosed with endometrial cancer were included in a pragmatic cluster randomized trial at 12 hospitals in the Netherlands and were randomly assigned to SCP or usual care (n = 221; 75% response). The SCP was generated using the web-based Registrationsystem Oncological GYnecology (ROGY) and provided tailored information regarding disease, treatment, and possible late-effects. Cancer-related use of general practitioner, specialist, and additional health care was collected through questionnaires after diagnosis and at 6-, 12-, and 24-month follow-up and compared using linear multilevel regression analyses.
Results
Women who received an SCP had more cancer-related primary care visits compared to the usual care arm during the first year after diagnosis (β = 0.7, p < 0.01). At 6-month follow-up, women in the SCP group used more additional health care compared to women receiving usual care (24 vs. 11%, p = 0.04). Women with anxious symptoms (p = 0.03) and women who received radiotherapy (p = 0.01) had a higher primary care use within the first year after treatment, when receiving an SCP.
Conclusions
The SCP increases primary health care consumption the first year after treatment, particularly in women treated with radiotherapy and women with anxious symptoms.
Implications for cancer survivors
These findings imply that the SCP enables women in need of supportive care to seek relevant care at an early stage after treatment. Whether this results in improved patient-reported outcomes in the long-term needs to be further studied.
Similar content being viewed by others
References
Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists : challenges to assuring access to oncology services. J Oncol Pract Am Soc Clin Oncol. 2007;3:79–86.
Grunfeld E, Earle CC. The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr. 2010;2010:25–30.
Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA. Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31:2322–36.
Stovall E, Greenfield S, Hewitt M, others. From Cancer Patient to Cancer Survivor: Lost in Transition. National Academies Press; 2005.
Mayer DK, Birken SA, Check DK, Chen RC. Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013). Cancer. 2015;121:978–96.
Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29:4755–62.
Boekhout AH, Maunsell E, Pond GR, Julian JA, Coyle D, Levine MN, et al. A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial. J. Cancer Surviv. Res. Pract. 2015;9:683–91.
Hershman DL, Greenlee H, Awad D, Kalinsky K, Maurer M, Kranwinkel G, et al. Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat. 2013;138:795–806.
Brothers BM, Easley A, Salani R, Andersen BL. Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol. 2013;129:554–8.
Jefford M, Gough K, Drosdowsky A, Russell L, Aranda S, Butow P, et al. A randomized controlled trial of a nurse-led supportive care package (survivorcare) for survivors of colorectal cancer. Oncologist. 2016;21:1014–23.
Emery JD, Jefford M, King M, Hayne D, Martin A, Doorey J, et al. ProCare trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer. BJU Int. 2017;119:381–9.
Kvale EA, Huang C-HS, Meneses KM, Demark-Wahnefried W, Bae S, Azuero CB, et al. Patient-centered support in the survivorship care transition: outcomes from the patient-owned survivorship care plan intervention. Cancer. 2016;122:3232–42.
Maly RC, Liang L-J, Liu Y, Griggs JJ, Ganz PA. Randomized controlled trial of survivorship care plans among low-income, predominantly latina breast cancer survivors. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35:1814–21.
van de Poll-Franse LV, Nicolaije KAH, Vos MC, Pijnenborg JMA, Boll D, Husson O, et al. The impact of a cancer survivorship care plan on gynecological cancer patient and health care provider reported outcomes (ROGY care): study protocol for a pragmatic cluster randomized controlled trial. Trials. 2011;12:256.
Nicolaije KAH, Ezendam NPM, Vos MC, Pijnenborg JMA, Boll D, Boss EA, et al. Impact of an automatically generated cancer survivorship care plan on patient-reported outcomes in routine clinical practice: longitudinal outcomes of a pragmatic, cluster randomized trial. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33:3550–9.
Ezendam NPM, Nicolaije KAH, Kruitwagen RFPM, Pijnenborg JMA, Vos MC, Boll D, et al. Survivorship care plans to inform the primary care physician: results from the ROGY care pragmatic cluster randomized controlled trial. J Cancer Surviv Res Pract. 2014;8:595–602.
Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156–63.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
Bottomley A, Flechtner H, Efficace F, Vanvoorden V, Coens C, Therasse P, et al. Health related quality of life outcomes in cancer clinical trials. Eur J Cancer Oxf Engl. 1990;2005(41):1697–709.
Greimel E, Nordin A, Lanceley A, Creutzberg CL, van de Poll-Franse LV, Radisic VB, et al. Psychometric validation of the European organisation for research and treatment of cancer quality of life questionnaire-endometrial cancer module (EORTC QLQ-EN24). Eur J Cancer Oxf Engl. 1990;2011(47):183–90.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
Carey M, Noble N, Sanson-Fisher R, MacKenzie L. Identifying psychological morbidity among people with cancer using the hospital anxiety and depression scale: time to revisit first principles? Psychooncology. 2012;21:229–38.
Vodermaier A, Millman RD. Accuracy of the hospital anxiety and depression scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2011;19:1899–908.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77.
Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101:1464–88.
Twisk JWR. Applied multilevel analysis: a practical guide for medical researchers. 1 edition. Cambridge: Cambridge University Press; 2006.
Hill-Kayser CE, Vachani CC, Hampshire MK, Di Lullo G, Jacobs LA, Metz JM. Impact of internet-based cancer survivorship care plans on health care and lifestyle behaviors. Cancer. 2013;119:3854–60.
Ezendam NPM, Nicolaije KAH, Boll D, Lybeert MLM, Mols F, Pijnenborg JMA, et al. Health care use among endometrial cancer survivors: a study from PROFILES, a population-based survivorship registry. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2013;23:1258–65.
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Wiley Online Library; 2011.
Gundgaard J, Ekholm O, Hansen EH, Rasmussen NK. The effect of non-response on estimates of health care utilisation: linking health surveys and registers. Eur J Pub Health. 2008;18:189–94.
Funding
The ROGY (Registration System Oncology Gynecology) Care Trial was supported by Grant No. UVT-2010-4743 from the Dutch Cancer Society. The Dutch Cancer Society did not contribute to the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in the study were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Jeppesen, M.M., Ezendam, N.P.M., Pijnenborg, J.M.A. et al. The impact of the survivorship care plan on health care use: 2-year follow-up results of the ROGY care trial. J Cancer Surviv 12, 18–27 (2018). https://doi.org/10.1007/s11764-017-0639-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-017-0639-7